Clinical Pharmacology Studies. Phase 1.
Abstract
The scientific work of this year centered around the bioavailability, safety, tolerance, pharmacokinetics and pharmacodynamics of pyridostigmine; and the absorption, safety, tolerance and pharmacokinetics of single doses of WR 6026. These two studies were completed successfully and efficiently, and complete details can be found in the draft Task Reports which have been submitted. These drafts are in the process of review and revision by Division of Experimental Therapeutics personnel prior to publication of final Task Reports.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 15, 1987
- Accession Number
- ADA181670
Entities
People
- Brent G. Petty
- David M. Kornhauser
- Paul S. Lietman
Organizations
- Johns Hopkins University